Leadership Overview
Cordis US has 7 executives leading key functions including strategy, operations, finance, human resources, and regional leadership.
Driven by innovation, Cordis US is dedicated to advancing interventional cardiovascular technologies, developing minimally invasive devices to treat cardiovascular diseases and improve patient outcomes globally.
Driven by innovation, Cordis US is dedicated to advancing interventional cardiovascular technologies, developing minimally invasive devices to treat cardiovascular diseases and improve patient outcomes globally.
Leadership Roles at Cordis US
Duke Rohlen - Chief Executive Officer
Duke Rohlen, the Chief Executive Officer at Cordis US, directs the company's overall strategic vision and operational execution. Rohlen guides the development and manufacturing of minimally invasive devices, including guidewires, catheters, balloons, stents, and vascular closure systems, essential for treating coronary and peripheral vascular diseases. This leadership role involves fostering innovation across the organization, ensuring Cordis US maintains its position as a global leader in interventional cardiovascular technologies. Rohlen's oversight extends to driving market expansion and enhancing the company's reputation built on over 60 years of experience. By championing a culture of excellence, Duke Rohlen ensures the company consistently delivers high-quality medical devices that improve patient lives and address critical healthcare needs worldwide.

Anthony Kim - Director & Chief of Staff to CEO
Anthony Kim, the Director & Chief of Staff to CEO at Cordis US, provides strategic support and operational coordination directly to the Chief Executive Officer. Kim facilitates key initiatives, manages critical projects, and ensures seamless communication across executive functions, enhancing the CEO's effectiveness. This role involves close collaboration on the strategic direction for Cordis US's interventional cardiovascular technologies, including guidewires, catheters, balloons, stents, and vascular closure systems. Anthony Kim plays a pivotal part in driving the company's mission to advance minimally invasive treatments for cardiovascular diseases. The Chief of Staff's ability to streamline operations and align strategic priorities is essential for maintaining Cordis US's leadership in the medical device sector.
Hernan Domenico - Head Chief Financial Officer, Finance (Americas)
Hernan Domenico, the Head Chief Financial Officer, Finance (Americas) at Cordis US, directs all financial operations and strategic fiscal planning for the Americas region. Domenico manages financial reporting, budgeting, forecasting, and investment strategies, ensuring robust financial health and compliance. This role involves overseeing financial performance related to the development and manufacturing of interventional cardiovascular technologies, including guidewires, catheters, balloons, stents, and vascular closure systems. Hernan Domenico collaborates with executive leadership to identify opportunities for financial optimization and sustainable growth, supporting the company's mission to treat cardiovascular diseases. The Chief Financial Officer's expertise is crucial in guiding fiscal decisions that underpin Cordis US's market presence and commitment to innovation in medical devices.
Champ Davis - Chief Operating Officer
Champ Davis, the Chief Operating Officer at Cordis US, oversees the day-to-day operational functions critical to the company's success. Davis manages the complex manufacturing processes for Cordis US's extensive portfolio of interventional cardiovascular technologies, ensuring efficiency and quality control. This involves optimizing supply chain logistics and production workflows for minimally invasive devices such as guidewires, catheters, balloons, stents, and vascular closure systems. Champ Davis works closely with other executive leaders to align operational capabilities with strategic growth objectives, particularly in the development and delivery of solutions for coronary and peripheral vascular diseases. The Chief Operating Officer's focus remains on driving operational excellence and supporting the company's mission to advance patient care through innovative medical devices.
Matthew Muscari - President, Americas
Matthew Muscari, the President, Americas at Cordis US, directs the company's commercial strategy and operational performance across North and South America. Muscari oversees sales, marketing, and distribution efforts for Cordis US's comprehensive range of interventional cardiovascular technologies, including guidewires, catheters, balloons, stents, and vascular closure systems. This leadership position is critical for expanding market share and driving revenue growth within the Americas region, focusing on treatments for coronary and peripheral vascular diseases. Matthew Muscari collaborates with global leadership to ensure regional operations align with the company's overarching mission and commitment to innovation in medical devices. The President, Americas' focus is on strengthening customer relationships and delivering exceptional value to healthcare providers and patients.
Bryan Loo - President, Asia Pacific
Bryan Loo, the President, Asia Pacific at Cordis US, spearheads the company's strategic initiatives and business development throughout the Asia Pacific region. Loo is responsible for driving market penetration and operational excellence for Cordis US's interventional cardiovascular technologies, including guidewires, catheters, balloons, stents, and vascular closure systems. This role involves adapting global strategies to meet the unique demands of diverse markets within the Asia Pacific, focusing on treating cardiovascular diseases. Bryan Loo works to build strong partnerships with healthcare professionals and distributors, ensuring access to advanced medical devices. The President, Asia Pacific's leadership is instrumental in expanding Cordis US's global footprint and reinforcing its commitment to improving patient outcomes across this vital region.

Nancy Pounder - Chief Human Resources Officer
Nancy Pounder, the Chief Human Resources Officer at Cordis US, leads all human capital strategies and initiatives to support the company's global workforce. Pounder oversees talent acquisition, employee development, compensation and benefits, and organizational culture, ensuring a high-performing and engaged team. This leadership function is vital for attracting and retaining the specialized talent required for developing and manufacturing advanced interventional cardiovascular technologies, such as guidewires, catheters, balloons, stents, and vascular closure systems. Nancy Pounder works to align HR policies with Cordis US's strategic goals, fostering an environment that drives innovation in treating cardiovascular diseases. The Chief Human Resources Officer's dedication to employee well-being and professional growth is fundamental to the company's long-term success and its mission in medical devices.
Explore Leadership Teams in Manufacturing
Solventum will embody its mission of enabling better, smarter, safer healthcare to improve lives. With a dedicated focus on solving big healthcare challenges, the independent healthcare company will push the boundaries of health, material and datascience to improve outcomes across the healthcare ecosystem. Its diverse product portfolio spans across the healthcare industry from medical solutions and oral care to health information systems and separation and purification sciences.
Company Leadership LY
GG
JX
LifeNet Health is a nonprofit organization dedicated to advancing the field of regenerative medicine through innovative transplantation and cellular solutions. The organization provides comprehensive tissue and organ donation services while supporting healthcare providers, researchers, and patients worldwide. By combining cutting-edge medical technology with rigorous quality standards, LifeNet Health enables life-saving procedures and regenerative therapies that enhance patient outcomes and improve quality of life.
Company Leadership JS
RT
JB
JC
Dental Implant & Denture Laboratory in Staten Island, New York At our laboratory, we work with you and your patients as a team. Let us help you successfully complete your dental implant cases. Our dental consultants discuss the specifics of any case with you. Ask us about our complete denture services today. We make traditional dentures and partials, and we offer additional dentures at additional cost. With a strong commitment to the dental professional, we offer several dental seminars. We want to keep our customers educated on the current trends and technology. Contact us today in Staten Island, New York , when you need services from a dental implant and denture laboratory you can trust. With more than 40 years of experience, the staff at our dental implant and denture laboratory in Staten Island, New York, is a select group of technicians experienced in implant dentistry. Since 1985, Specialized Dental Implants & Restoration has been committed to your success. We offer a large variety of options and we have the knowledge and experience to achieve long-term predictable results. We are committed to returning your work on a timely schedule, and we accept most leading major credit cards for your convenience. Check back frequently for more information on how we can benefit your practice by providing quality restorations that add value to your service.
Company Leadership LB
RR
DS
Elcam Medical is a leading manufacturer of disposable medical devices and components tailored for the OEM market, specializing in innovative flow control solutions. Their product range includes stopcocks, manifolds, and various accessories designed for critical medical applications such as Intensive Care, Anesthesia, Dialysis, and Interventional Cardiology. The company focuses on providing customized solutions that enhance safety and efficiency in medical procedures. Elcam Medical partners with top industry players to ensure high-quality standards and effective fluid management in healthcare.
Company Leadership YH
MG
ID
AH